HCP check
HCP check

Welcome to SHPT Challenges

This website contains information about secondary hyperparathyroidism (SHPT). It is intended to provide information to an international audience outside of the USA.

You are now leaving our website and heading to a third-party website that we do not operate. We are not responsible for the content of the third-party website. You are advised to review its privacy policy as it may differ from ours.

Are you sure you want to leave?

Confirm

Cancel

SHPT is associated
with increased
morbidity, mortality
and disease
progression
in patients with
ND-CKD7

/sites/g/files/brlbcj1106/files/2020-04/bricks-min-min.png

COMPARED WITH PATIENTS WITHOUT SHPT,
PATIENTS WITH SHPT ARE >5X MORE LIKELY
TO BE INITIATED ON DIALYSIS OR DIE7

/sites/g/files/brlbcj1106/files/2020-06/Kaplan%E2%80%93Meier_analysis_Graph-min.png

CKD: chronic kidney disease; ND-CKD: non-dialysis chronic kidney disease; SHPT: secondary hyperparathyroidism.